Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.08% | 61.59 | 0.0% | $953.82m | |
| GILD | Gilead Sciences, Inc. | -1.14% | 76.06 | 1.0% | $768.72m | |
| AMGN | Amgen, Inc. | 8.17% | 255.12 | 1.3% | $748.85m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.32% | 609.17 | 2.5% | $678.56m | |
| NVAX | Novavax, Inc. | -4.38% | 79.70 | 102.0% | $606.94m | |
| BIIB | Biogen, Inc. | -1.04% | 264.77 | 1.6% | $543.38m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.39% | 286.28 | 1.9% | $524.18m | |
| ILMN | Illumina, Inc. | -0.49% | 368.55 | 3.5% | $308.59m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.13% | 112.39 | 2.0% | $229.11m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.03% | 125.84 | 4.3% | $214.73m | |
| SGEN | Seattle Genetics, Inc. | -1.41% | 167.52 | 6.1% | $201.85m | |
| SRNE | Sorrento Therapeutics, Inc. | 10.35% | 6.93 | 1.8% | $186.93m | |
| SRPT | Sarepta Therapeutics, Inc. | 3.33% | 165.68 | 13.9% | $168.66m | |
| INCY | Incyte Corp. | -1.27% | 102.65 | 2.5% | $160.00m | |
| IMMU | Immunomedics, Inc. | 4.15% | 36.91 | 11.0% | $154.32m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.